Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06438445 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 22, 2025 to Dec 22, 2026
    • Study completion date: Apr 5, 2026 to Apr 5, 2027
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: May 30, 2024 to Dec 22, 2025
    • Study completion date: Dec 5, 2024 to Apr 5, 2026
    • Start date changed from estimate of May 30, 2024 to Jul 30, 2024
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence in patients with chronic kidney disease (CKD) on hemodialysis (HD).
Trial Details
NCT Number NCT06438445
Lead Sponsor Universidade Federal Fluminense
Conditions
(from sponsor)		 Kidney Failure, Chronic, Oxidative Stress, Hemodialysis
Related terms Kidney Failure, Chronic, Renal Insufficiency, Chronic
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov